Statin use may slow the progression of osteoarthritis (OA) of the knee but does not appear to affect the rate of OA progression in the hip, according to a recently published prospective observational study. For the analysis, x-rays of the hip and knee were examined at baseline and again an…
Read more »
Lumbosacral radiculopathy does not improve significantly more with epidural steroids vs saline injections 1 month following treatment, according to results from a multicenter, randomized trial. The study also looked at functional capacity, and injections of etanercept fared worse than steroids or saline. In the study, which was conducted in the…
Read more »
Metal-on-metal hip implants do not increase the risk of cancer in the short term after the surgery, according to an examination of a national joint registry of arthroplasties, a recent study found. The study investigators, from the United Kingdom, based their research on data from the National Joint Registry of…
Read more »
Algorithms that predict risk for venous thromboembolism occurring outside of the hospital setting should be reevaluated to include infection, erythropoiesis-stimulating agents, and blood transfusion, in addition to the more commonly recognized triggers such as major surgeries, fractures, immobility, and chemotherapy, according to a recent study. “The notion that VTE occurs…
Read more »
Regular use of proton-pump inhibitors (PPIs) can increase the risk for hip fracture in postmenopausal women, especially those with a history of smoking, according to a study published recently in the British Medical Journal (BMJ). Key Point: Postmenopausal women who are regular users of PPIs have an increased risk of…
Read more »
Vitamin D is associated with a lower risk of developing stress fractures, especially among very active girls who engage in at least 1 hour of high-impact activity per day. Vitamin D deficiency is common in all ages in India, according to recent studies. Marwaha and Sripathy noted a high prevalence…
Read more »
indicates a Peer-Reviewed Article
Bisphosphonates linked to atypical femoral fracture
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »